Winter 25-hydroxyvitamin D levels in young urban adults are affected by smoking, body mass index and educational level

European Journal of Clinical Nutrition

Volumn 69, Issue 3, 2015, Pages 355-360

  Shinkov, A ^a   Borissova, A M ^a   Dakovska, L ^a   Vlahov, J ^a   Kassabova, L ^a   Svinarov, D ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; CALCIFEDIOL; VITAMIN D;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BULGARIAN (PEOPLE); CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; MARRIAGE; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; RISK ASSESSMENT; RURAL AREA; SEX DIFFERENCE; SMOKING; STRUCTURED QUESTIONNAIRE; SUN EXPOSURE; URBAN AREA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; WINTER; YOUNG ADULT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BLOOD; BULGARIA; COMPLICATION; MIDDLE AGED; RISK; RISK FACTOR; SEASON; URBAN POPULATION;

ADULT; BODY MASS INDEX; BULGARIA; CALCIFEDIOL; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PARATHYROID HORMONE; PREVALENCE; RISK FACTORS; SEASONS; SEX FACTORS; SMOKING; URBAN POPULATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84924557596     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.163     Document Type: Article

References (40)

1. Van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011; 25: 671-680.
2. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64: 203-209.
3. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L et al. Vitamin D de ficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. Eur J Endocrinol 2012; 167: 553-560.
4. Welsh J. Vitamin D and cancer: integration of cellular biology, molecular mechanisms and animal models. Scand J Clin Lab Invest Suppl 2012; 243: 103-111.
5. Hewison M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl 2012; 243 : 92-102.
6. Bogh MKB. Vitamin D production after UVB: aspects of UV-related and personal factors. Scand J Clin Lab Invest Suppl 2012; 243: 24-31.
7. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011; 91: 115-124.
8. Chan J, Jaceldo-Siegl K, Fraser GE. Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites. Cancer Causes Control 2010; 21: 501-511.
9. Grant WB. Role of solar UV irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries. Dermatoendocrinol 2012; 4: 203-211.
10. Borissova AM, Shinkov A, Vlahov J, Dakovska L, Todorov T, Svinarov D et al. Vitamin D status in Bulgaria-winter data. Arch Osteoporos 2013; 8: 133-138.
11. Bischoff-Ferrari H a. 'Vitamin D - why does it matter?' - defining vitamin D deficiency and its prevalence. Scand J Clin Lab Invest Suppl 2012; 243: 3-6.
12. Ross a C, Manson JE, Abrams S a, Aloia JF, Brannon PM, Clinton SK et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
13. Borissova A-M, Shinkov A, Vlahov J, Dakovska L, Todorov T, Svinarov D et al. Determination of the optimal level of 25(OH)D in the Bulgarian population. Endokrinologya 2012; 17: 135-142.
14. FDA. Guidance for Industry Bioanalytical Method Validation. Rockville 2001.
15. Souberbielle JC, Courbebaisse M, Cormier C, Pierrot-Deseilligny C, Viard JP, Jean G et al. When should we measure vitamin D concentration in clinical practice? Scand J Clin Lab Invest Suppl 2012; 243: 129-135.
16. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D de ficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
17. Pludowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013; 64: 319-327.
18. Larose TL, Chen Y, Camargo CA, Langhammer A, Romundstad P, Mai XM. Factors associated with vitamin D deficiency in a Norwegian population: the HUNT Study. J Epidemiol Community Health 2014; 68: 165-170.
19. Hadjinikolova L, Hubenova T, Zaikov A. Status and development tendencies of freshwater aquaculture production in Bulgaria. Bulg J Agric Sci 2010; 16: 398-405.
20. Park S, Lee BK. Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged ≥ 50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract 2012; 6: 162-168.
21. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF. Serum 25-hydroxyvitamin D status of the US population : 1988-1994 compared with 2000-2004 1-3. Am J Clin Nutr 2008; 88: 1519-1527.
22. Daly R, Gagnon C, Lu Z, Magliano D, Dunstan D, Sikaris K et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) 2012; 77: 26-35.
23. Genzen JR, Gosselin JT, Wilson TC, Racila E, Krasowski MD. Analysis of vitamin D status at two academic medical centers and a national reference laboratory: result patterns vary by age, gender, season, and patient location. BMC Endocr Disord 2013; 13: 52.
24. Greene-Finestone LS, Berger C, de Groh M, Hanley DA, Hidiroglou N, Sarafin K et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 2011; 22: 1389-1399.
25. McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, Koenig K et al. Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 21-35.
26. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860-868.
27. Shirazi L, Almquist M, Malm J, Wirfält E, Manjer J. Determinants of serum levels of vitamin D: a study of life-style, menopausal status, dietary intake, serum calcium, and PTH. BMC Womens Health 2013; 13: 33.
28. Tepper S, Shahar DR, Geva D, Ish-Shalom S. Predictors of serum 25(Oh)D increase following bimonthly supplementation with 100,000IU vitamin D in healthy, men aged 25-65 years. J Steroid Biochem Mol Biol 2013; e-pub ahead of print 12 December 2013; doi:10.1016/j.jsbmb.2013.12.005.
29. Drincic AT, Armas L a G, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012; 20: 1444-1448.
30. Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 2009; 39: 256-258.
31. Metheniti D, Sakka S, Dracopoulou M, Margeli A, Papassotiriou I, Kanaka- Gantenbein C et al. Decreased circulating 25-(OH) vitamin D concentrations in obese female children and adolescents: positive associations with retinol binding protein-4 and neutrophil gelatinase-associated lipocalin. Hormones (Athens) 2013; 12: 397-404.
32. González-Molero I, Rojo-Martínez G, Morcillo S, Gutierrez C, Rubio E, Pérez-Valero V et al. Hypovitaminosis D and incidence of obesity: a prospective study. Eur J Clin Nutr 2013; 67: 680-682.
33. Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A et al. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One 2013; 8: e68689.
34. Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes 2012; 36: 387-396.
35. Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue-the effect of obesity and diet-induced weight loss. Int J Obes 2013; 37: 651-657.
36. Wong KE, Kong J, Zhang W, Szeto FL, Ye H, Deb DK et al. Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. J Biol Chem 2011; 286: 33804-33810.
37. Soldin OP, Makambi KH, Soldin SJ, O'Mara DM. Steroid hormone levels associated with passive and active smoking. Steroids 2011; 76: 653-659.
38. Szulc P, Garnero P, Claustrat B, Marchand F, Duboeuf F, Delmas PD. Increased bone resorption in moderate smokers with low body weight: The Minos Study. J Clin Endocrinol Metab. Endocri Soc 2002; 87: 666-674.
39. Supervía A, Nogués X, Enjuanes A, Vila J, Mellibovsky L, Serrano S et al. Effect of smoking and smoking cessation on bone mass, bone remodeling, vitamin D, PTH and sex hormones. J Musculoskelet Neuronal Interact 2006; 6: 234-241.
40. Borissova A-M, Shinkov A, Vlahov J, Dakovska L, Todorov T, Svinarov D et al. Comparative analisis on distribution of deficiency and insufficiency of vitamin D in diferent types living places in Bulgaria. Endokrinologya 2013; 17: 143-157.